The use of CD47-modified biomaterials to mitigate the immune response.
about
Thrombospondin-1, free radicals, and the coronary microcirculation: the aging conundrum.Effects of age-related shifts in cellular function and local microenvironment upon the innate immune response to implants.Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications.Effects of aging upon the host response to implants.
P2860
The use of CD47-modified biomaterials to mitigate the immune response.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The use of CD47-modified biomaterials to mitigate the immune response.
@en
The use of CD47-modified biomaterials to mitigate the immune response.
@nl
type
label
The use of CD47-modified biomaterials to mitigate the immune response.
@en
The use of CD47-modified biomaterials to mitigate the immune response.
@nl
prefLabel
The use of CD47-modified biomaterials to mitigate the immune response.
@en
The use of CD47-modified biomaterials to mitigate the immune response.
@nl
P2093
P2860
P356
P1476
The use of CD47-modified biomaterials to mitigate the immune response.
@en
P2093
Jillian E Tengood
Robert J Levy
Stanley J Stachelek
P2860
P304
P356
10.1177/1535370216647130
P577
2016-05-10T00:00:00Z